A funding flashpoint, Pfizer’s $1B poster and AstraZeneca advertising

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a bispecific antibody newly licensed by Pfizer.

Jun 1, 2025 - 17:35
 0
A funding flashpoint, Pfizer’s $1B poster and AstraZeneca advertising

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a bispecific antibody newly licensed by Pfizer.